Skip to main content
·8 min read·RedLightOS Team

Red Light Therapy During Pregnancy: What We Know and Don't Know

Published: Last updated:
pregnancysafetywomen's health
Updated Mar 20268 min read read
R

Written by RedLightOS Research Team · Photobiomodulation Research, Clinical Protocol Development

Last updated March 15, 2026Medical information reviewed for accuracy

You are pregnant, your lower back aches constantly, and your red light therapy panel has been your go-to pain relief tool for months. Now you are wondering: is it safe to keep using it? A quick internet search gives you twenty different answers, half of them from people selling devices and the other half from forums where nobody cites a single study.

The uncertainty is stressful. You want relief, but you also do not want to take any unnecessary risks during pregnancy. And here is the honest, uncomfortable truth: the scientific community does not have a definitive answer for you. There are almost no human studies examining red light therapy during pregnancy, which means anyone who tells you "it's completely safe" or "it's definitely dangerous" is speaking beyond what the evidence supports.

What we can do is lay out what we know, what we do not know, and what most healthcare providers recommend — so you can have an informed conversation with your OB/GYN or midwife.

TL;DR: There is insufficient research to confirm that red light therapy is safe during pregnancy. The light is non-ionizing and non-thermal at standard doses, which are reassuring characteristics. However, the lack of human studies during pregnancy means the precautionary principle applies. Most practitioners recommend avoiding it, particularly over the abdomen and lower back. Always consult your OB/GYN before using any red light therapy device during pregnancy.

The Short Answer

We do not have enough evidence to declare red light therapy safe or unsafe during pregnancy. No major clinical trials have studied photobiomodulation in pregnant women as a primary population. The handful of relevant data points come from animal studies, in-vitro research, and theoretical analysis of the therapy's mechanisms.

Because pregnancy is a period where the precautionary principle carries extra weight — where "probably safe" is not good enough — the responsible recommendation is to consult your healthcare provider before using red light therapy during pregnancy and to avoid treatment over the abdomen and lower back near the uterus unless specifically cleared by your doctor.

This is not a satisfying answer. But it is the honest one.

What We Know From Research

The Limited Evidence Available

The research landscape for red light therapy during pregnancy is sparse. Here is what exists:

Animal studies have examined photobiomodulation effects on pregnant rodents and found no clear evidence of harm to offspring at standard therapeutic doses. However, animal studies have well-known limitations in translating to human pregnancy outcomes. Rodent physiology, gestation periods, and tissue depths differ significantly from humans.

In-vitro cell studies show that red and near-infrared light at therapeutic doses (1-30 J/cm²) does not damage DNA, does not cause mutations, and does not produce ionizing radiation effects. These studies are reassuring at a cellular level but do not address the complexity of a developing fetus within a living human body.

Phototherapy for neonatal jaundice is an established, well-studied medical treatment that uses blue light (not red/NIR) on newborns. While the wavelengths differ, it demonstrates that light-based therapy can be used safely in extremely vulnerable populations when properly studied and controlled. This does not prove red light therapy is safe during pregnancy, but it counters the notion that all light therapies are inherently dangerous.

Dental and dermatological studies have occasionally included pregnant women who received low-level laser therapy (LLLT) for conditions like oral lesions, and no adverse outcomes were reported in these cases. However, these were incidental inclusions, not controlled studies designed to assess safety in pregnancy.

What the Studies Do Not Show

No study has demonstrated that red light therapy at standard therapeutic doses causes harm during pregnancy. But absence of evidence of harm is not the same as evidence of safety. The critical distinction is that researchers have not specifically investigated the question with the rigor required to draw a safety conclusion.

Why There Is Limited Data

The lack of research is not an oversight. It reflects a deliberate ethical framework in medical research.

Pregnant women are a protected population in research ethics. Institutional review boards (IRBs) apply heightened scrutiny to studies involving pregnant participants. Researchers must demonstrate that the question cannot be answered with non-pregnant participants and that potential benefit justifies potential risk. For red light therapy — which is not treating a life-threatening condition — the ethical bar is high.

Liability concerns and funding priorities further limit research. Device manufacturers face legal exposure if a study participant experiences an adverse pregnancy outcome, and research funding flows toward higher-priority reproductive health questions.

The result is a genuine evidence gap that is unlikely to be filled soon.

Theoretical Safety Considerations

While direct evidence is lacking, we can examine the physical and biological characteristics of red light therapy to assess theoretical risk:

Factors That Suggest Lower Risk

  • Non-ionizing radiation. Red (660nm) and near-infrared (850nm) light are non-ionizing — they do not carry enough energy per photon to break chemical bonds or damage DNA. This is fundamentally different from X-rays, gamma rays, or even UV light, all of which are ionizing and known to pose risks during pregnancy.

  • Non-thermal at standard doses. Consumer LED panels operating at typical irradiance levels (50-200 mW/cm²) do not raise tissue temperature meaningfully during normal treatment durations. Hyperthermia (elevated body temperature) is a known risk factor in pregnancy, particularly in the first trimester. Standard red light therapy does not produce this effect.

  • Limited penetration depth. Red light at 660nm penetrates approximately 8-10mm. Even near-infrared at 850nm penetrates approximately 40-50mm. In a pregnant woman, the uterus is surrounded by layers of skin, adipose tissue, muscle, and fascia that absorb and scatter photons. The amount of therapeutic light energy that could reach a developing fetus through these layers is extremely small, particularly as pregnancy progresses and tissue depth increases.

  • Mechanism of action. Red light therapy works by interacting with cytochrome c oxidase in mitochondria, promoting ATP production and reducing oxidative stress. These are fundamental cellular processes, not drug-like interactions with specific receptors. There is no known mechanism by which enhanced mitochondrial function in maternal surface tissue would adversely affect fetal development.

Factors That Warrant Caution

  • Biological effects on developing tissue. While the mechanisms of photobiomodulation are generally well-understood in mature tissue, developing fetal tissue may respond differently. Fetal cells are rapidly dividing and differentiating — processes that could theoretically be influenced by any external stimulus, including light energy, even at low levels.

  • Increased blood flow. Red light therapy promotes vasodilation and increased local blood flow. While this is beneficial in most contexts, altered blood flow patterns near the uterus during pregnancy are a theoretical concern, particularly if treatment is applied directly to the abdominal area.

  • Unknown cumulative effects. A single session is unlikely to pose risk. But a protocol of daily sessions over weeks — common in red light therapy — creates cumulative exposure that has not been studied in pregnancy.

  • Individual variation. Pregnancy itself changes the body in ways that could alter the response to red light therapy. Hormonal changes, increased blood volume, altered skin pigmentation, and changes in tissue composition may all affect how light interacts with maternal tissue.

What Practitioners Recommend

The majority of healthcare providers and red light therapy practitioners who address this topic recommend one of two approaches:

Conservative Approach (Most Common)

Avoid red light therapy entirely during pregnancy. This is the recommendation from most device manufacturers' safety guidelines and from healthcare providers who apply the precautionary principle strictly. The reasoning is simple: with insufficient evidence to confirm safety, the prudent choice is to abstain until more data is available.

Modified Approach (Some Practitioners)

Allow red light therapy on extremities only, with restrictions. Some practitioners and healthcare providers consider limited use acceptable under specific conditions:

  • Avoid the abdomen and lower back entirely. No treatment over or near the uterus.
  • Limit to extremities. Hands, feet, lower legs, and forearms — areas far from the developing fetus.
  • Use lower doses. Reduce treatment time and increase treatment distance to minimize energy delivery.
  • Use 660nm only, not 850nm. Red light has shallower penetration than NIR, limiting any energy that could potentially reach deeper tissue.
  • Do not start new protocols during pregnancy. If a woman was not using red light therapy before pregnancy, practitioners typically recommend not starting during pregnancy.

Neither approach is based on strong evidence. Both are precautionary frameworks reflecting the absence of data rather than the presence of it.

Areas to Avoid During Pregnancy

If you and your healthcare provider decide that limited red light therapy use is acceptable during your pregnancy, the following areas should be strictly avoided:

  • Abdomen — directly over the uterus at any stage of pregnancy
  • Lower back — the lumbar region, where light could penetrate toward the uterus from behind
  • Pelvis and hips — adjacent areas that could allow scattered photons to reach reproductive structures
  • Upper thighs — close proximity to the pelvic region

These restrictions apply regardless of wavelength (660nm or 850nm) and regardless of dose. The precautionary principle dictates avoiding any direct treatment near the developing fetus.

Alternative Approaches During Pregnancy

If you are looking for the benefits typically associated with red light therapy during pregnancy, discuss these alternatives with your healthcare provider:

  • Warm (not hot) compresses for localized pain relief
  • Prenatal massage for muscle tension and pain management
  • Gentle stretching and prenatal yoga for flexibility and pain reduction
  • Physical therapy for musculoskeletal pain, particularly lower back pain
  • TENS (transcutaneous electrical nerve stimulation) — some units are approved for use during pregnancy (consult your provider)
  • Topical treatments approved for pregnancy for skin conditions
  • Cold therapy for acute inflammation and swelling

These alternatives have more established safety profiles during pregnancy and can address many of the same symptoms that red light therapy targets.

After Pregnancy: Resuming Red Light Therapy

After delivery, red light therapy can generally be resumed. For post-cesarean wound healing, discuss timing with your surgeon — most recommend waiting until initial healing is complete. Postpartum skin concerns (stretch marks, tone changes) and musculoskeletal recovery (lower back pain, perineal healing) are well-suited treatment targets. Red light therapy does not produce systemic effects that transfer through breast milk, so most practitioners consider it compatible with breastfeeding, though avoiding direct treatment on breast tissue during lactation is a reasonable precaution.

The Bottom Line

Always consult your OB/GYN or midwife before using red light therapy during pregnancy. This is not a formality — it is a genuine recommendation based on the absence of sufficient safety data.

Red light therapy is non-ionizing, non-thermal at standard doses, and works through well-understood cellular mechanisms. These characteristics are reassuring. However, reassuring is not the same as proven safe. No responsible source can tell you that red light therapy is definitively safe during pregnancy, because the studies that would prove this have not been conducted.

Your healthcare provider knows your specific pregnancy, your health history, and your risk factors. They are the right person to help you weigh the potential benefits against the unknown risks and make a decision that is right for your situation.

What We Don't Know Yet

  • Whether any amount of red light therapy poses risk during pregnancy. The absence of adverse event reports is encouraging but does not constitute safety evidence.
  • Trimester-specific considerations. The first trimester involves the most critical period of organ development. Whether risk profiles differ by trimester is completely unstudied.
  • Dose thresholds during pregnancy. If there is a safe dose range during pregnancy, we do not know what it is.
  • Long-term effects on offspring. No studies have tracked developmental outcomes in children whose mothers used red light therapy during pregnancy.
  • Whether photobiomodulation affects pregnancy hormones. Progesterone, estrogen, and other hormones critical to pregnancy maintenance have not been studied in the context of photobiomodulation.

Frequently Asked Questions

Can red light therapy cause a miscarriage?

There is no evidence that red light therapy causes miscarriage. However, there is also no research specifically investigating this question. The non-ionizing, non-thermal nature of red light therapy makes a causal link unlikely based on known mechanisms, but "unlikely based on theory" is different from "proven safe through research." Discuss any concerns with your healthcare provider.

Is it safe to be in the same room as a red light therapy device while pregnant?

Yes. Being in the same room as an operating red light therapy panel — without being directly in the treatment beam — poses no known risk. The light energy dissipates rapidly with distance and the indirect, ambient exposure from being nearby is negligible. This is comparable to being in a room with any other light source.

My partner uses red light therapy — is there any risk to my pregnancy?

No. Red light therapy used by another person in your household poses no risk to your pregnancy. The therapy's effects are local to the tissue being treated. There is no radiation exposure, no chemical byproducts, and no environmental residue that could affect another person.

I used red light therapy before I knew I was pregnant. Should I be worried?

If you used red light therapy during early pregnancy before knowing you were pregnant, there is no established reason for concern based on current knowledge. The therapy is non-ionizing and non-thermal. Mention it to your healthcare provider at your next appointment for documentation purposes, but the theoretical risk profile does not suggest cause for alarm. Many women have incidentally received phototherapy of various kinds during early pregnancy without reported adverse outcomes.


Have questions about red light therapy protocols? Talk to your healthcare provider first, then explore evidence-based dosing.

Learn about dosing →

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. This article is not a substitute for consultation with a qualified healthcare provider. Red light therapy is not intended to diagnose, treat, cure, or prevent any disease. Pregnant women should always consult their obstetrician, midwife, or other qualified healthcare provider before using any form of light therapy, including red light therapy and near-infrared therapy. The information in this article reflects the state of available research and should not be interpreted as a recommendation for or against the use of red light therapy during pregnancy. Individual circumstances vary, and only your healthcare provider can advise you on what is appropriate for your specific situation.

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.

Continue Reading